Literature DB >> 12666172

Comparison of the conformation and electrostatic surface properties of magainin peptides bound to sodium dodecyl sulfate and dodecylphosphocholine micelles.

Rickey P Hicks1, Erin Mones, Hanah Kim, Brandon W Koser, Daniel A Nichols, Apurba K Bhattacharjee.   

Abstract

The role played by noncovalent interactions in inducing a stable secondary structure onto the sodium dodecyl sulfate (SDS) and dodecylphosphocholine (DPC) micelle-bound conformations of (Ala(8,13,18))magainin 2 amide and the DPC micelle bound conformation of magainin 1 were determined. Two-dimensional NMR and molecular modeling investigations indicated that (Ala(8,13,18))magainin 2 amide bound to DPC micelles adopts a alpha-helical secondary structure involving residues 2-16. The four C-terminal residues converge to a lose beta-turn structure. (Ala(8,13,18))magainin 2 amide bound to SDS miscelles adopts a alpha-helical secondary structure involving residues 7-18. The C- and N-terminal residues exhibited a great deal of conformational flexibility. Magainin 1 bound to DPC micelles adopts a alpha-helical secondary structure involving residues 4-19. The C-terminal residues converge to a lose beta-turn structure. The results of this investigation indicate hydrophobic interactions are the major contributors to stabilizing the induced helical structure of the micelle-bound peptides. Electrostatic interactions between the polar head groups of the micelle and the cationic side chains of the peptides define the positions along the peptide backbone where the helical structures begin and end. Published 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666172     DOI: 10.1002/bip.10325

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  7 in total

1.  Effect of micelle interface on the binding of anticoccidial PW2 peptide.

Authors:  Luzineide W Tinoco; Francisco Gomes-Neto; Ana Paula Valente; Fabio C L Almeida
Journal:  J Biomol NMR       Date:  2007-10-10       Impact factor: 2.835

2.  Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents.

Authors:  Wojciech G Lesniak; Emilia Sikorska; Hassan Shallal; Babak Behnam Azad; Ala Lisok; Mrudula Pullambhatla; Martin G Pomper; Sridhar Nimmagadda
Journal:  Mol Pharm       Date:  2015-02-03       Impact factor: 4.939

3.  Quasiracemate Crystal Structures of Magainin 2 Derivatives Support the Functional Significance of the Phenylalanine Zipper Motif.

Authors:  Zvi Hayouka; Nicole C Thomas; David E Mortenson; Kenneth A Satyshur; Bernard Weisblum; Katrina T Forest; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2015-09-10       Impact factor: 15.419

4.  Evidence for phenylalanine zipper-mediated dimerization in the X-ray crystal structure of a magainin 2 analogue.

Authors:  Zvi Hayouka; David E Mortenson; Dale F Kreitler; Bernard Weisblum; Katrina T Forest; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2013-10-08       Impact factor: 15.419

5.  NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles.

Authors:  Fernando Porcelli; Raffaello Verardi; Lei Shi; Katherine A Henzler-Wildman; Ayyalusamy Ramamoorthy; Gianluigi Veglia
Journal:  Biochemistry       Date:  2008-04-26       Impact factor: 3.162

6.  Structural Model of the Bilitranslocase Transmembrane Domain Supported by NMR and FRET Data.

Authors:  Amrita Roy Choudhury; Emilia Sikorska; Johannes van den Boom; Peter Bayer; Łukasz Popenda; Kosma Szutkowski; Stefan Jurga; Massimiliano Bonomi; Andrej Sali; Igor Zhukov; Sabina Passamonti; Marjana Novič
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

7.  Real-time measurement of membrane conformational states induced by antimicrobial peptides: balance between recovery and lysis.

Authors:  Kristopher Hall; Tzong-Hsien Lee; Adam I Mechler; Marcus J Swann; Marie-Isabel Aguilar
Journal:  Sci Rep       Date:  2014-06-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.